Cite
HARVARD Citation
Pollet, J. et al. (2021). SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Human vaccines & immunotherapeutics. 17 (8), pp. 2356-2366. [Online].